Shukra Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	636.73	325.87	745.73	588.34	204.86	111.96
Other Revenue	8.96	-	-	6.59	-0	-
Revenue	645.69	325.87	745.73	594.93	204.86	111.96
Revenue Growth (YoY)	93.34%	-56.30%	25.35%	190.41%	82.97%	-5.49%
Cost of Revenue	118.52	82.92	445.34	454.25	105.17	27.69
Gross Profit	527.17	242.95	300.39	140.68	99.69	84.27
Selling, General & Admin	95.08	72.02	81.76	53.83	55.4	44.76
Other Operating Expenses	42.29	16.36	2.03	21.88	14.94	21.97
Operating Expenses	171.16	118.43	104.29	94.09	86.96	81.47
Operating Income	356.02	124.52	196.09	46.59	12.73	2.8
Interest Expense	-10.32	-5.21	-2.76	-2.56	-2.81	-0.13
Interest & Investment Income	14.79	14.79	5.59	0.64	0.31	0.47
Other Non Operating Income (Expenses)	-0.74	-0.74	-0.09	-0.25	-0.05	-0.2
EBT Excluding Unusual Items	359.75	133.37	198.83	44.42	10.18	2.93
Other Unusual Items	-	-	-	-	-	-1.95
Pretax Income	359.75	133.37	198.83	44.42	10.18	0.98
Income Tax Expense	68.14	37.61	13.46	0.35	2.67	-0.9
Net Income	291.61	95.75	185.37	44.07	7.51	1.88
Net Income to Common	291.61	95.75	185.37	44.07	7.51	1.88
Net Income Growth	256.72%	-48.35%	320.68%	486.98%	299.10%	428.31%
Shares Outstanding (Basic)	735	438	438	67	63	63
Shares Outstanding (Diluted)	735	438	438	67	63	63
Shares Change (YoY)	68.39%	-	551.03%	7.38%	-	0.02%
EPS (Basic)	0.40	0.22	0.42	0.66	0.12	0.03
EPS (Diluted)	0.40	0.22	0.42	0.66	0.12	0.03
EPS Growth	111.84%	-48.35%	-35.38%	446.67%	299.10%	428.20%
Free Cash Flow	-	51.75	-69.57	-13.22	64.39	-12.54
Free Cash Flow Per Share	-	0.12	-0.16	-0.20	1.03	-0.20
Dividend Per Share	-	0.010	0.100	0.013	0.013	-
Dividend Growth	-	-90.00%	700.00%	-	-	-
Gross Margin	81.64%	74.55%	40.28%	23.65%	48.66%	75.27%
Operating Margin	55.14%	38.21%	26.30%	7.83%	6.21%	2.50%
Profit Margin	45.16%	29.38%	24.86%	7.41%	3.66%	1.68%
Free Cash Flow Margin	-	15.88%	-9.33%	-2.22%	31.43%	-11.20%
EBITDA	393.23	154.57	216.59	64.96	29.35	17.53
EBITDA Margin	60.90%	47.43%	29.04%	10.92%	14.33%	15.66%
D&A For EBITDA	37.21	30.05	20.5	18.38	16.62	14.74
EBIT	356.02	124.52	196.09	46.59	12.73	2.8
EBIT Margin	55.14%	38.21%	26.30%	7.83%	6.21%	2.50%
Effective Tax Rate	18.94%	28.20%	6.77%	0.79%	26.26%	-
Revenue as Reported	687.76	367.94	773.88	600.3	205.67	115.52
Advertising Expenses	-	3.63	21.21	0.1	0.09	0.41

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.